Journal profile · Medicine-Infectious Diseases
New Microbes and New Infections
ISSN 2052-2975 · Elsevier · United Kingdom
New Microbes and New Infections: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 6 (journal website); fully open access; APC about USD 2,830; median 120 days to acceptance (96 articles, last 24 months); 133 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
New Microbes and New Infections is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Bacterial Identification and Susceptibility Testing, Genomics and Phylogenetic Studies and Antibiotic Resistance in Bacteria, together about 27.6% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
New Microbes and New Infections (NMNI) is a journal which publishes cutting-edge papers on all aspects of emerging microbes and infections as well as papers on "old microbes" with a new presentation such as drug resistant malaria, antimicrobial resistant bacteria, re-emerging infections or organisms in new hosts or vectors.NMNI publishes articles on new microbes that are evolving from existing organisms and infections in new populations or appearing in new geographic area. It publishes high quality systematic reviews, narrative reviews, cutting-edge original research and rapid analyses of traditional and emerging infections as well as editorials, short correspondence pieces and special issues that can be rapidly reviewed and published.Submissions on preparedness of healthcare infrastructures, governments or international organisations to detect, characterize and mitigate emerging microbial threats are welcome.The journal publishes topics including:• Travel acquired infections • Infection outbreaks • Predictions/examples showing the expansion of a microbe to a new ecological niche or an expanded geographic area due to climate change. • One Health. Emerging infections and their links/origins to the animal world. • Manipulation of microbes in the lab and considers organisms of bioterror. • Antimicrobials • Preventive approaches and therapies to combat novel microbes or changing infections
From the journal's Aims & Scope
Research area (LetPub): Medicine-Infectious Diseases
Editor-in-chief Patricia Schlagenhauf SubmissionPublisher website
Editorial board by country: 6 in mainland China (about 14%); most named Switzerland 8, Mainland China 6, Sweden 5, United States 2, United Kingdom 2 (44 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology10.8%
- Genomics and Phylogenetic StudiesBiochemistry, Genetics and Molecular Biology10.6%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology6.2%
- Viral Infections and VectorsMedicine5.4%
- Mosquito-borne diseases and controlMedicine5.2%
- Gut microbiota and healthBiochemistry, Genetics and Molecular Biology4.8%
- SARS-CoV-2 and COVID-19 ResearchMedicine4.7%
- COVID-19 Clinical Research StudiesMedicine4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Microbiology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Microbiology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 6Publisher website ·
- CiteScore 2026-06
- 3.9LetPub ·
- CiteScore (publisher)
- 3.9Publisher website ·
- SJR 2026-06
- 0.34LetPub ·
- SNIP 2026-06
- 0.75LetPub ·
- h-index
- 62OpenAlex ·
- i10-index
- 629OpenAlex ·
- 2-year mean citedness
- 1.87OpenAlex ·
- Self-citation rate
- 5%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 75LetPub ·
Articles by year OpenAlex count · 1,897 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 162 | 162 | 58 |
| 2025 | 133 | 133 | 367 |
| 2024 | 341 | 341 | 763 |
| 2023 | 134 | 134 | 1,008 |
| 2022 | 122 | 122 | 895 |
| 2021 | 113 | 113 | 1,802 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
120 daysMedian, submission to acceptance · P25–P75 61 days – 192 days
- Acceptance to online
- median 1 days (96 articles)
- Submission to online
- median 121 days
- Sample
- 96 articles with submission and acceptance dates (383 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 8 weeksLetPub ·
- Submission to publication (journal-reported)
- about 22 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,830 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,770 / EUR 2,530 / GBP 2,220 / JPY 343,560 | — | — | |
| LetPub | USD 2,190 | Yes | — | |
| Publisher website | USD 2,830 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers4, by deadline
Publisher websiteWhat to prepare2 items from the author guidelines
- Keywords
- 1–7
- Highlights
- Optional
Article types accepted9, with length limits
- "first sighting""First Sighting" Category can be "New Species Announcement" or "Emergence of a microbe in a new geographic area" Unstructured abstract (up to 50 words) 500 word…Length not stated
- editorialEditorial (usually invited)Letter to the EditorNo abstract5 keywordsBegin with "Dear Editor"700 words maximum (no subheadings)1 table/figure maximum5 references…main text ≤ 700 words · abstract ≤ 700 words · references ≤ 5
- editorial (usually invited)Editorial (usually invited)Length not stated
- letterEditorial (usually invited)Letter to the EditorNo abstract5 keywordsBegin with "Dear Editor"700 words maximum (no subheadings)1 table/figure maximum5 references…Length not stated
- letter to the editorLetter to the Editor No abstract 5 keywords Begin with "Dear Editor" 700 words maximum (no subheadings) 1 table/figure maximum 5 references maximumLength not stated
- mini-narrative reviewMini-Narrative Review Unstructured abstract (up to 200 words) 10 keywords 3000 words maximum 6 tables/figures maximum 50 references maximumLength not stated
- original articleOriginal Article Structured abstract (up to 250 words, with sections, 'background', 'methods', 'results', 'conclusions') 5-10 keywords 2500 words maximum 6 to 8…Length not stated
- reviewEditorial (usually invited)Letter to the EditorNo abstract5 keywordsBegin with "Dear Editor"700 words maximum (no subheadings)1 table/figure maximum5 references…Length not stated
- systematic review (according to prisma guidelines)Systematic Review (according to PRISMA guidelines) Structured abstract (up to 250 words, with sections, 'background', 'methods', 'results', 'conclusions') 5-10 …Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Elsevier's Publishing Ethics Policy Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Double anonymized peer review Model summary
This journal follows a double anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2052-2975
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about New Microbes and New Infections
What CAS zone is New Microbes and New Infections in?
In the 2025 upgraded edition of the CAS Journal Ranking, New Microbes and New Infections is in Zone 4 of Medicine, and in Zone 4 of the minor category Infectious Diseases / Microbiology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of New Microbes and New Infections?
The journal's website gives an impact factor of 6; this is the journal's own figure, as LetPub lists none for it; CiteScore 3.9, h-index 62.
How long does peer review take at New Microbes and New Infections?
Based on the dates recorded on 96 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 120 days (interquartile range 61–192 days); authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of New Microbes and New Infections?
According to the journal's author guidelines: Keywords: 1–7; Highlights: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of New Microbes and New Infections based?
Of the 44 board members whose country the journal's board page names, 6 (about 14%) are in mainland China; the countries named most often are Switzerland (8), Mainland China (6) and Sweden (5). Counted from the institutions listed on the board page; for reference only.
Which databases index New Microbes and New Infections?
According to LetPub and DOAJ records, New Microbes and New Infections is indexed in ESCI, Scopus and DOAJ.
Is New Microbes and New Infections open access, and what is the APC?
New Microbes and New Infections is a fully open-access journal. APC about USD 2,830.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .